Epithelial to Mesenchymal Transition Tumors: Fallacious or Snail's Pace?
Cardiff
Robert D
RD
Center for Comparative Medicine, Department of Pathology and Laboratory Medicine, University of California, Davis School of Medicine, Davis, California 95616, USA. rdcardiff@ucdavis.edu
D000818:Animals; D002289:Carcinoma, Non-Small-Cell Lung / Q000145:classification / Q000188:drug therapy / Q000473:pathology*; D045744:Cell Line, Tumor; D004848:Epithelium / Q000473:pathology; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000145:classification / Q000188:drug therapy / Q000473:pathology*; D008648:Mesoderm / Q000473:pathology; D051379:Mice; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011799:Quinazolines / Q000627:therapeutic use
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride